Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...
It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...
CRISPR technique can target single genes essential for cancer cell survival, toppling the whole structure, says nanomedicine ...
The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...
Racehorses in Britain are to be tested for gene doping as part of a new initiative by the British Horseracing Authority.
AccurEdit Therapeutics today announced that its innovative in vivo gene editing product, ART001, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA).
Verve received FDA IND clearance for VERVE-102 to treat HeFH, adding new trial sites in the United States. Read more about ...
On Tuesday, the team behind the plan to bring mammoth-like animals back to the tundra announced the creation of what it is ...
Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
The Chinese scientist who was imprisoned for secretly creating the world’s first genetically-engineered babies has claimed he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback